BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12707710)

  • 1. [Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients].
    Rades D; Fehlauer F; Schild S; Lamszus K; Alberti W
    Strahlenther Onkol; 2003 Apr; 179(4):213-8. PubMed ID: 12707710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of atypical neurocytomas.
    Rades D; Fehlauer F; Schild SE
    Cancer; 2004 Feb; 100(4):814-7. PubMed ID: 14770439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the best available treatment for neurocytomas in children.
    Rades D; Schild SE; Fehlauer F
    Cancer; 2004 Dec; 101(11):2629-32. PubMed ID: 15494975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas.
    Rades D; Schild SE
    Cancer; 2006 Mar; 106(5):1140-3. PubMed ID: 16400638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Well-differentiated neurocytoma: what is the best available treatment?
    Rades D; Fehlauer F; Lamszus K; Schild SE; Hagel C; Westphal M; Alberti W
    Neuro Oncol; 2005 Jan; 7(1):77-83. PubMed ID: 15701284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of meningeal melanocytomas.
    Rades D; Schild SE; Tatagiba M; Molina HA; Alberti W
    Cancer; 2004 Jun; 100(11):2442-7. PubMed ID: 15160350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is 50 Gy sufficient to achieve long-term local control after incomplete resection of typical neurocytomas?
    Rades D; Schild SE
    Strahlenther Onkol; 2006 Jul; 182(7):415-8. PubMed ID: 16826361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central neurocytoma: management recommendations based on a 35-year experience.
    Leenstra JL; Rodriguez FJ; Frechette CM; Giannini C; Stafford SL; Pollock BE; Schild SE; Scheithauer BW; Jenkins RB; Buckner JC; Brown PD
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1145-54. PubMed ID: 17187939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-effect relationship for radiotherapy after incomplete resection of atypical neurocytomas.
    Rades D; Fehlauer F; Ikezaki K; Schild SE
    Radiother Oncol; 2005 Jan; 74(1):67-9. PubMed ID: 15683672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site.
    Rades D; Raabe A; Bajrovic A; Alberti W
    Strahlenther Onkol; 2004 Mar; 180(3):144-7. PubMed ID: 14991201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma.
    Chen YD; Li WB; Feng J; Qiu XG
    Radiat Oncol; 2014 Nov; 9():242. PubMed ID: 25373333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of postoperative radiotherapy for the treatment of gangliogliomas.
    Rades D; Zwick L; Leppert J; Bonsanto MM; Tronnier V; Dunst J; Schild SE
    Cancer; 2010 Jan; 116(2):432-42. PubMed ID: 19908258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of postoperative radiotherapy after resection of a single brain metastasis. Combined analysis of 643 patients.
    Nieder C; Astner ST; Grosu AL; Andratschke NH; Molls M
    Strahlenther Onkol; 2007 Oct; 183(10):576-80. PubMed ID: 17896090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment recommendations for the various subgroups of neurocytomas.
    Rades D; Schild SE
    J Neurooncol; 2006 May; 77(3):305-9. PubMed ID: 16575540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
    Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
    Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients.
    Ogawa K; Toita T; Nakamura K; Uno T; Onishi H; Itami J; Shikama N; Saeki N; Yoshii Y; Murayama S
    Cancer; 2003 Jul; 98(2):369-76. PubMed ID: 12872359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for central neurocytoma.
    Rades D; Fehlauer F
    Neurology; 2002 Oct; 59(8):1268-70. PubMed ID: 12391364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central neurocytoma: long-term outcomes of multimodal treatments and management strategies based on 30 years' experience in a single institute.
    Kim JW; Kim DG; Kim IK; Kim YH; Choi SH; Han JH; Park CK; Chung HT; Park SH; Paek SH; Jung HW
    Neurosurgery; 2013 Mar; 72(3):407-13; discussion 413-4. PubMed ID: 23208055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.